Existing prostate diagnostics, like the PSA biomarker and digital rectal examination, cause widespread underdiagnosis, overdiagnosis and overtreatment, with dire societal and human being costs, Dr. Shtern said. Current diagnostics miss and/or underestimate the level or aggressiveness of prostate tumor and lead to treatment failures in as much as half of all men. Fake diagnostic alarms result in a staggering extent of needless treatment and biopsies, costing billions of dollars each year. As many as 54 % of guys with early prostate cancer undergo unneeded treatment and are left with life-altering complications, such as incontinence and impotence. Improved diagnostic tools, including more specific variations of biomarkers and advanced imaging tools to steer treatment and biopsies, helps you to save lives, enable minimal invasive and the very best patient care, reduce unneeded procedures, and decrease health care costs..Additionally, just 20 % of these surveyed were alert to the Medicare credit of $600 designed for low-income Medicare beneficiaries to help them pay for prescription drugs. When they learn about the Medicare credit, a lot more than four out of five believe it will be beneficial to low-income Medicare beneficiaries, including two-thirds who think it shall be very helpful. Related StoriesMembers signed up for Medicare Advantage satisfied with their plans, study findsGenomic Health announces Medicare protection for Oncotype DX prostate tumor testTissue Regenix strengthens placement in post-acute wound treatment market with Medicare protection for Dermapure’The Pharmacy Care Alliance survey demonstrates Medicare beneficiaries who need the most help with their prescription medication costs are wanting to learn even more and eager to have the assistance the Medicare medication discount cards will provide,’ stated Mary Ann Wagner, customer and president health advisor for the Pharmacy Care Alliance.